Citigroup Inc. (C)

Sector:Financials
Super Investor Stats:
Ownership count:7
Ownership rank:44
% of all portfolios:0.538%
Hold Price * :$62.60
History Portfolio Manager Activity ▲ Share change % change to portfolio
Q3  2024
≡ Richard Pzena - Hancock Classic Value Add 0.19% 1,692 0.01
≡ Greenhaven Associates Add 1.46% 242,545 0.18
≡ Samantha McLemore - Patient Capital Management Reduce 7.29% 121,252 0.37
≡ Kahn Brothers Group Reduce 0.69% 8,279 0.09
Q2  2024
≡ Greenhaven Associates Add 2.14% 349,086 0.29
≡ Richard Pzena - Hancock Classic Value Reduce 30.09% 385,941 2.12
≡ Samantha McLemore - Patient Capital Management Reduce 6.41% 113,965 0.38
≡ Kahn Brothers Group Reduce 0.38% 4,594 0.05
≡ Leon Cooperman Sell 100.00% 300,000 0.79
≡ Michael Burry - Scion Asset Management Sell 100.00% 125,000 7.64
Q1  2024
≡ Greenhaven Associates Add 1.11% 178,455 0.10
≡ Michael Burry - Scion Asset Management Add 25.00% 25,000 1.53
≡ Richard Pzena - Hancock Classic Value Reduce 12.84% 188,900 0.71
≡ Samantha McLemore - Patient Capital Management Reduce 5.94% 112,256 0.35
≡ Kahn Brothers Group Reduce 0.82% 9,922 0.09
≡ Lee Ainslie - Maverick Capital Sell 100.00% 7,369 0.01
Q4  2023
≡ Samantha McLemore - Patient Capital Management Add 0.37% 6,902 0.02
≡ Steven Romick - FPA Crescent Fund Add 21.20% 778,922 0.67
≡ Greenhaven Associates Add 22.40% 2,948,512 1.62
≡ Lee Ainslie - Maverick Capital Buy 7,369 0.01
≡ Michael Burry - Scion Asset Management Buy 100,000 5.44
≡ Leon Cooperman Reduce 57.14% 400,000 0.97
≡ Kahn Brothers Group Reduce 0.52% 6,316 0.05
Q3  2023
≡ Kahn Brothers Group Add 0.74% 8,878 0.06
≡ Steven Romick - FPA Crescent Fund Add 2.85% 101,769 0.07
≡ Greenhaven Associates Add 20.00% 2,193,883 1.17
≡ Samantha McLemore - Patient Capital Management Add 24.99% 376,413 0.91
Q2  2023
≡ Greenhaven Associates Add 8.82% 889,450 0.54
≡ Leon Cooperman Add 77.22% 305,000 0.76
≡ Samantha McLemore - Patient Capital Management Add 914.84% 1,357,616 3.48
≡ Kahn Brothers Group Reduce 0.88% 10,747 0.07
≡ Bruce Berkowitz - Fairholme Capital Sell 100.00% 82,500 0.32
≡ Bill Miller - Miller Value Partners Sell 100.00% 1,099,482 3.22
Q1  2023
≡ Warren Buffett - Berkshire Hathaway Add 0.16% 89,000 0.00
≡ Kahn Brothers Group Add 4.20% 49,021 0.33
≡ Bill Miller - Miller Value Partners Add 6.66% 68,614 0.20
≡ Samantha McLemore - Patient Capital Management Add 9.28% 12,600 0.26
≡ Greenhaven Associates Add 31.23% 2,399,160 1.75
≡ Bruce Berkowitz - Fairholme Capital Reduce 52.15% 89,900 0.35
≡ Richard Pzena - Hancock Classic Value Reduce 15.16% 262,884 0.83
≡ Lee Ainslie - Maverick Capital Sell 100.00% 8,151 0.01
≡ Bill Nygren - Oakmark Select Fund Sell 100.00% 4,012,000 4.45
Q4  2022
≡ Kahn Brothers Group Add 0.49% 5,741 0.03
≡ Greenhaven Associates Add 6.32% 456,730 0.37
≡ Lee Ainslie - Maverick Capital Add 34.15% 2,075 0.00
≡ Bill Nygren - Oakmark Select Fund Reduce 19.95% 1,000,000 1.11
≡ Richard Pzena - Hancock Classic Value Reduce 13.27% 265,329 0.73
≡ Bruce Berkowitz - Fairholme Capital Reduce 0.98% 1,700 0.01
≡ Bill Miller - Miller Value Partners Reduce 0.56% 5,760 0.02
≡ ValueAct Capital Sell 100.00% 10,992,637 7.76
Q3  2022
≡ Kahn Brothers Group Add 4.31% 47,993 0.31
≡ Greenhaven Associates Add 10.09% 661,950 0.58
≡ Bill Nygren - Oakmark Select Fund Add 24.93% 1,000,000 1.04
≡ Lee Ainslie - Maverick Capital Buy 6,076 0.01
≡ Richard Pzena - Hancock Classic Value Reduce 7.62% 165,027 0.37
≡ Bill Miller - Miller Value Partners Reduce 4.46% 48,441 0.12
≡ Bruce Berkowitz - Fairholme Capital Reduce 1.02% 1,800 0.01
Q2  2022
≡ Bill Nygren - Oakmark Select Fund Add 1.78% 69,990 0.08
≡ Richard Pzena - Hancock Classic Value Add 5.61% 114,945 0.24
≡ Bill Miller - Miller Value Partners Add 11.77% 114,262 0.29
≡ Kahn Brothers Group Add 14.67% 142,651 0.88
≡ Bruce Berkowitz - Fairholme Capital Add 20.31% 29,700 0.11
≡ Greenhaven Associates Add 22.18% 1,191,580 1.18
≡ Samantha McLemore - Patient Capital Management Add 30.58% 31,800 0.72
≡ Leon Cooperman Add 107.89% 205,000 0.65
≡ ValueAct Capital Reduce 20.61% 2,853,470 2.09
Q1  2022
≡ Kahn Brothers Group Add 8.77% 78,359 0.53
≡ Richard Pzena - Hancock Classic Value Add 9.09% 170,742 0.31
≡ Greenhaven Associates Add 18.66% 844,900 1.20
≡ Bruce Berkowitz - Fairholme Capital Add 631.00% 126,200 0.39
≡ Bill Miller - Miller Value Partners Add 1665.10% 915,807 1.86
≡ Warren Buffett - Berkshire Hathaway Buy 55,155,797 0.81
≡ Samantha McLemore - Patient Capital Management Buy 104,000 2.19
≡ Leon Cooperman Reduce 50.00% 190,000 0.53
≡ Lee Ainslie - Maverick Capital Sell 100.00% 1,974 0.00
Q4  2021
≡ Kahn Brothers Group Add 7.31% 60,852 0.50
≡ Richard Pzena - Hancock Classic Value Add 12.87% 214,258 0.42
≡ Bruce Berkowitz - Fairholme Capital Buy 20,000 0.08
≡ Greenhaven Associates Buy 4,527,140 6.91
≡ Lee Ainslie - Maverick Capital Reduce 94.86% 36,440 0.00
≡ Bill Miller - Miller Value Partners Reduce 88.62% 428,421 0.93
≡ Thomas Gayner - Markel Group Sell 100.00% 21,020 0.02
Q3  2021
≡ Bill Nygren - Oakmark Select Fund Add 2.07% 80,010 0.11
≡ Richard Pzena - Hancock Classic Value Add 20.74% 285,954 0.70
≡ Lee Ainslie - Maverick Capital Add 1307.62% 35,685 0.03
≡ ValueAct Capital Reduce 33.26% 6,899,597 5.61
≡ Bill Miller - Miller Value Partners Reduce 31.02% 217,409 0.52
≡ Kahn Brothers Group Reduce 0.47% 3,970 0.04
Q2  2021
≡ Bill Miller - Miller Value Partners Add 0.19% 1,306 0.00
≡ Kahn Brothers Group Add 0.72% 6,023 0.06
≡ Thomas Gayner - Markel Group Add 1.94% 400 0.00
≡ Lee Ainslie - Maverick Capital Reduce 76.60% 8,931 0.00
≡ Francis Chou - Chou Associates Reduce 14.77% 10,000 0.41
≡ ValueAct Capital Reduce 4.50% 978,015 0.77
≡ Steven Romick - FPA Crescent Fund Reduce 1.76% 63,963 0.06
≡ Harry Burn - Sound Shore Sell 100.00% 340,300 2.07
Q1  2021
≡ Kahn Brothers Group Add 1.73% 14,124 0.16
≡ Leon Cooperman Add 2.70% 10,000 0.05
≡ Richard Pzena - Hancock Classic Value Add 7.25% 93,172 0.31
≡ Lee Ainslie - Maverick Capital Add 221.04% 8,028 0.01

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.